Altered thyrotropic and lactotropic axes regulation in Huntington's disease

Clinical Endocrinology

Volumn 73, Issue 4, 2010, Pages 540-545

  Aziz, N A ^a   Pijl, Hanno ^a   Frölich, Marijke ^a   Roelfsema, Ferdinand ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; LIOTHYRONINE; PROLACTIN; THYROTROPIN; THYROXINE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CAG REPEAT; CLINICAL ARTICLE; CONTROLLED STUDY; ENTROPY; FEMALE; HORMONAL REGULATION; HUMAN; HUNTINGTON CHOREA; LIOTHYRONINE BLOOD LEVEL; MALE; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; PROLACTIN; RECEPTORS, DOPAMINE D2; THYROID HORMONES; THYROTROPIN;

EID: 77957035525     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03836.x     Document Type: Article

References (32)

1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971 983.
2. Aziz, N.A., van der Burg, J.M., Landwehrmeyer, G.B. et al. (2008) Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 71, 1506 1513.
3. Petersen, A., Hult, S. Kirik, D. (2009) Huntington's disease - new perspectives based on neuroendocrine changes in rodent models. Neuro-degenerative Diseases 6, 154 164.
4. van der Burg, J.M., Bacos, K., Wood, N.I. et al. (2008) Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease 29, 41 51.
5. Lalic, N.M., Maric, J., Svetel, M. et al. (2008) Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Archives of Neurology 65, 476 480.
6. Martin, B., Golden, E., Carlson, O.D. et al. (2008) Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies and extends survival in a mouse model of Huntington's disease. Diabetes 58, 318 328.
7. Aziz, N.A., Swaab, D.F., Pijl, H. et al. (2007) Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Reviews in the Neurosciences 18, 223 251.
8. Freeman, M.E., Kanyicska, B., Lerant, A. et al. (2000) Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80, 1523 1631.
9. Zoeller, R.T., Tan, S.W. Tyl, R.W. (2007) General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology 37, 11 53.
10. Lavin, P.J., Bone, I. Sheridan, P. (1981) Studies of hypothalamic function in Huntington's chorea. Journal of Neurology, Neurosurgery and Psychiatry 44, 414 418.
11. Saleh, N., Moutereau, S., Durr, A. et al. (2009) Neuroendocrine disturbances in Huntington's disease. PLoS ONE 4, e4962.
12. Goodman, A.O., Murgatroyd, P.R., Medina-Gomez, G. et al. (2008) The metabolic profile of early Huntington's disease - a combined human and transgenic mouse study. Experimental Neurology 210, 691 698.
13. Hayden, M.R. Vinik, A.I. (1979) Disturbances in hypothalamic-pituitary hormonal dopaminergic regulation in Huntington's disease. In : T.N. Chase, N.S. Wexler, A. Barbeau eds Advances in Neurology. Raven Press, New York, pp. 305 317.
14. Nance, M.A. Sanders, G. (1996) Characteristics of individuals with Huntington disease in long-term care. Movement Disorders 11, 542 548.
15. Kirkpatrick, B. Tamminga, C.A. (1988) The endocrinology of extrapyramidal system disorders. Neurologic Clinics 6, 159 172.
16. Markianos, M., Panas, M., Kalfakis, N. et al. (2009) Plasma homovanillic acid and prolactin in Huntington's disease. Neurochemical Research 34, 917 922.
17. Kremer, H.P., Roos, R.A., Frolich, M. et al. (1989) Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study. Journal of the Neurological Sciences 90, 335 344.
18. Veldhuis, J.D., Keenan, D.M. Pincus, S.M. (2008) Motivations and methods for analyzing pulsatile hormone secretion. Endocrine Reviews 29, 823 864.
19. Politis, M., Pavese, N., Tai, Y.F. et al. (2008) Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain 131 Pt 11 2860 2869.
20. Fitzgerald, P. Dinan, T.G. (2008) Prolactin and dopamine: what is the connection? A review article. Journal of Psychopharmacology 22 2 Suppl 12 19.
21. Kok, P., Roelfsema, F., Frolich, M. et al. (2009) Bromocriptine reduces augmented thyrotropin secretion in obese premenopausal women. Journal of Clinical Endocrinology and Metabolism 94, 1176 1181.
22. Huntington Study Group (1996) Unified Huntington's disease rating scale: reliability and consistency. Huntington Study Group. Movement Disorders 11, 136 142.
23. Aziz, N.A., Pijl, H., Frolich, M. et al. (2009) Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. Journal of Clinical Endocrinology and Metabolism 94, 1223 1228.
24. Johnson, M.L., Pipes, L., Veldhuis, P.P. et al. (2009) AutoDecon: a robust numerical method for the quantification of pulsatile events. Methods in Enzymology 454, 367 404.
25. Kok, P., Roelfsema, F., Langendonk, J.G. et al. (2005) High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. Journal of Clinical Endocrinology and Metabolism 90, 4659 4663.
26. Sievertsen, G.D., Lim, V.S., Nakawatase, C. et al. (1980) Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. Journal of Clinical Endocrinology and Metabolism 50, 846 852.
27. Pincus, S.M. Keefe, D.L. (1992) Quantification of hormone pulsatility via an approximate entropy algorithm. American Journal of Physiology 262 5 Pt 1 E741 E754.
28. Bjorkqvist, M., Petersen, A., Bacos, K. et al. (2006) Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Human Molecular Genetics 15, 1713 1721.
29. Farrer, L.A. Meaney, F.J. (1985) An anthropometric assessment of Huntington's disease patients and families. American Journal of Physical Anthropology 67, 185 194.
30. Trejo, A., Tarrats, R.M., Alonso, M.E. et al. (2004) Assessment of the nutrition status of patients with Huntington's disease. Nutrition 20, 192 196.
31. van der Burg, J.M., Bjorkqvist, M. Brundin, P. (2009) Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurology 8, 765 774.
32. Yamanaka, T., Tosaki, A., Miyazaki, H. et al. (2010) Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction. Human Molecular Genetics 19, 2099 2112.